Daniel A. Weiser
Impact in
- Neurology top 5%
- Neuroblastoma Research and Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Neurology 11
- Neuroblastoma Research and Treatments 11
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Yaël P. Mossé (2 shared papers)Wendy B. London (2 shared papers)Peter J. Huwe (1 shared paper)Hannah T. Ryles (1 shared paper)Kateryna Krytska (1 shared paper)Marci Laudenslager (1 shared paper)Scott C. Bresler (1 shared paper)Jin H. Park (1 shared paper)
- Journals
- Pediatric Blood & Cancer (5 papers)Cancer Research (4 papers)Translational Oncology (3 papers)Journal of Clinical Oncology (2 papers)Sarcoma (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Daniel A. Weiser
33 papers receiving 541 citations
Peers
Comparison fields: 5 of 76
- Neurology 250
- Cancer Research 158
- Oncology 140
- Pulmonary and Respiratory Medicine 129
- Molecular Biology 229
Countries citing papers authored by Daniel A. Weiser
This map shows the geographic impact of Daniel A. Weiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Weiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Weiser more than expected).
Fields of papers citing papers by Daniel A. Weiser
This network shows the impact of papers produced by Daniel A. Weiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Weiser. The network helps show where Daniel A. Weiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Weiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 262 | |
| 2 | 2019 | 42 | |
| 3 | 2018 | 38 | |
| 4 | 2013 | 33 | |
| 5 | 2018 | 24 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 17 | |
| 8 | 2022 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2018 | 13 | |
| 11 | 2011 | 11 | |
| 12 | 2019 | 7 | |
| 13 | 2015 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2017 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2017 | 2 |
About Daniel A. Weiser
Daniel A. Weiser is a scholar working on Neurology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 35 papers that have together received 546 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (11 papers), Sarcoma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Treatment and Pharmacology (2 papers), Bone Tumor Diagnosis and Treatments (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Neurology (250 citations), Cancer Research (158 citations), Oncology (140 citations), Pulmonary and Respiratory Medicine (129 citations) and Molecular Biology (229 citations). Daniel A. Weiser has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Yaël P. Mossé, Wendy B. London, Peter J. Huwe, Hannah T. Ryles, Kateryna Krytska, Marci Laudenslager, Scott C. Bresler, Jin H. Park, Ravi Radhakrishnan and Patrick McGrady. Their work appears in journals such as Pediatric Blood & Cancer, Cancer Research, Translational Oncology, Journal of Clinical Oncology and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.